EUVIMEDEUVIMED entdecken
Crossref

Remarkable Weight Reduction and HbA1c Improvement by Tirzepatide (Mounjaro) for Short Period

International Journal of Endocrinology and Diabetes · 01.05.2026 · 9 (2) · 1-4

DOI: 10.36266/ijed/206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Endocrinology and Diabetes, online erschienen am 01.05.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Remarkable Weight Reduction and HbA1c Improvement by Tirzepatide (Mounjaro) for Short Period. International Journal of Endocrinology and Diabetes, 9(2), 1-4. https://doi.org/10.36266/ijed/206

Vancouver

Remarkable Weight Reduction and HbA1c Improvement by Tirzepatide (Mounjaro) for Short Period. International Journal of Endocrinology and Diabetes. 2026;9(2):1-4. doi:10.36266/ijed/206

BibTeX
@article{euvimed2026,
  title = {Remarkable Weight Reduction and HbA1c Improvement by Tirzepatide (Mounjaro) for Short Period},
  journal = {International Journal of Endocrinology and Diabetes},
  year = {2026},
  volume = {9},
  number = {2},
  pages = {1--4},
  doi = {10.36266/ijed/206}
}
Kostenlos starten →